<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Brain expresses abundant lipocalin-type <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> (PG) D2 (<z:mp ids='MP_0002515'>PGD2</z:mp>) synthase but the role of <z:mp ids='MP_0002515'>PGD2</z:mp> and its metabolite, 15-deoxy-Delta(12,14) PGJ2 (15d-PGJ2) in brain protection is unclear </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study is to assess the effect of 15d-PGJ2 on neuroprotection </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Adenoviral transfer of cyclooxygenase-1 (Adv-COX-1) was used to amplify the production of 15d-PGJ2 in ischemic cortex in a rat focal infarction model </plain></SENT>
<SENT sid="3" pm="."><plain>Cortical 15d-PGJ2 in Adv-COX-1-treated rats was increased by 3-fold over control, which was correlated with reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and activated caspase 3, and increased peroxisome proliferator activated receptor-gamma (PPARgamma) and <z:chebi fb="4" ids="30413">heme</z:chebi> oxygenase-1 (HO-1) </plain></SENT>
<SENT sid="4" pm="."><plain>Intraventricular infusion of 15d-PGJ2 resulted in reduction of <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, which was abrogated by a PPARgamma inhibitor </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="50122">Rosiglitazone</z:chebi> infusion had a similar effect </plain></SENT>
<SENT sid="6" pm="."><plain>15d-PGJ2 and <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> at low concentrations suppressed <z:chebi fb="0" ids="30492">H2O2</z:chebi>-induced rat or human neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0001651'>necrosis</z:mp> and induced PPARgamma and HO-1 expression </plain></SENT>
<SENT sid="7" pm="."><plain>The anti-apoptotic effect was abrogated by PPARgamma inhibition </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: 15d-PGJ2 suppressed ischemic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0001651'>necrosis</z:mp> in a PPARgamma dependent manner </plain></SENT>
<SENT sid="9" pm="."><plain>15d-PGJ2 may play a role in controlling <z:hpo ids='HP_0011009'>acute</z:hpo> brain damage induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
</text></document>